GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59Zacks Investment Research • 04/17/25
Trump Tariff Plunge: 3 Phenomenal Stocks to Buy at Bargain Prices Right NowThe Motley Fool • 04/17/25
ACIP Votes to Expand Recommendation for Pfizer's RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of DiseaseBusiness Wire • 04/16/25
Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?The Motley Fool • 04/15/25
Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury'Investopedia • 04/14/25
Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giantWSJ • 04/14/25
As the market dips, I'm eyeing dividend plays like KO and PM – what stocks are on your buy list right now?24/7 Wall Street • 04/13/25